Advanced titanium implants designed to meet the rigorous clinical standards of Japan's leading medical institutions.
Japan represents one of the most sophisticated and demanding medical device markets globally. With a rapidly aging demographic, cardiothoracic surgeons in Japan are increasingly encountering complex patient profiles characterized by osteoporotic bone structures, diabetes, chronic obstructive pulmonary disease (COPD), and high body mass index (BMI). Traditional wire cerclage, while historically standard, carries an elevated risk of sternal dehiscence, deep sternal wound infections (DSWI), and mediastinitis in these vulnerable populations.
Rigid sternal fixation systems have emerged as the clinical gold standard to mitigate these risks. By providing rigid internal fixation using anatomically pre-contoured titanium plates and locking screws, these systems ensure superior mechanical stability, minimize micro-motion, and promote primary bone healing. For Japanese healthcare providers, adopting advanced sternal fixation systems translates directly to reduced intensive care unit (ICU) stays, lower reoperation rates, and significantly enhanced patient quality of life post-sternotomy.
Equipped with world-class manufacturing facilities and a rigorous quality management system to support Japanese medical distributors.
HBM Medical Apparatus And Instruments Co., Ltd. is a premier orthopedic medical equipment R&D, manufacturing, and operation enterprise in China. With a sales network covering the globe, HBM has established itself as a highly reliable partner for medical device distributors in Japan and beyond. Our production facility features 12 advanced production lines equipped with over 120 high-precision machining and testing instruments, ensuring an uninterrupted supply chain and unmatched manufacturing precision.
Our commitment to quality is backed by international certifications, including ISO 13485, MDSAP (Medical Device Single Audit Program), and CE (MDR). This robust regulatory framework guarantees that every sternal plate, rib plate, and locking screw we manufacture meets the uncompromising safety and efficacy standards required by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
Modern sternal fixation is shifting towards ultra-low-profile designs that minimize palpable hardware under the skin—a critical consideration for the typically smaller anatomical frames of Japanese patients. HBM's R&D team leverages advanced 3D modeling to design plates that conform precisely to the sternal anatomy, reducing the need for intraoperative bending and shortening surgical times.
The future of cardiothoracic implants lies in temporary scaffolding. HBM is actively researching bioresorbable magnesium alloys and advanced polymers that provide robust mechanical support during the critical 8-to-12-week sternal healing window, before gradually degrading and being absorbed by the body, leaving no permanent foreign material behind.
To support minimally invasive cardiac surgery (MICS) in Japan, HBM is developing patient-specific cutting and drilling guides. By integrating pre-operative CT scans with 3D printing, we enable surgeons to pre-plan screw trajectories and plate positioning with sub-millimeter accuracy, maximizing safety and clinical outcomes.
In the post-pandemic medical landscape, supply chain stability is a top priority for Japanese hospital networks and distributors. HBM Medical offers an unparalleled geographical and logistical advantage. Located in close proximity to major shipping hubs, we ensure rapid transit times to Japan, minimizing inventory holding costs for our partners.
Our raw materials are sourced exclusively from certified medical-grade titanium suppliers with 100% material traceability. With 12 dedicated production lines and a highly skilled workforce, HBM can scale production rapidly to meet sudden surges in market demand, ensuring that Japanese hospitals never face critical shortages of life-saving sternal closure implants.
Explore our extensive range of high-precision trauma plates, joint systems, and specialized surgical instruments.
Delivering high-precision orthopedic solutions through continuous scientific innovation and strict process control.
HBM Medical places talent development and scientific innovation at the core of its growth strategy. Our R&D team consists of 31 highly qualified engineers, including 1 Doctorate holder, 11 Postgraduates, and 17 Graduates specializing in biomedical engineering and metallurgy. This formidable team has launched over 25 new products in the past year alone, keeping HBM at the cutting edge of orthopedic and cardiothoracic implant technology.
We offer extensive customization options, including sample processing, graphic-based custom manufacturing, and on-demand development. This flexibility allows us to collaborate closely with Japanese clinical researchers to develop specialized implants tailored to unique anatomical requirements or novel surgical techniques.
To ensure 100% reliability in high-stakes cardiothoracic surgeries, HBM has implemented a comprehensive quality control system across all 12 production lines. Our 36 dedicated QA/QC inspectors oversee every phase of production, from raw material inspection to final sterile packaging. We guarantee full traceability of raw materials, utilizing advanced testing equipment to verify chemical composition, tensile strength, and fatigue resistance.
Our manufacturing processes comply fully with international standards, including ISO 13485 and MDSAP, ensuring that our products consistently meet or exceed the regulatory expectations of the Japanese Ministry of Health, Labour and Welfare (MHLW).
Addressing key technical, regulatory, and logistical inquiries for Japanese medical device distributors.
Elevate your clinical offerings and secure your medical device supply chain with HBM's PMDA-compliant, high-precision titanium implants.
Send Inquiry Now
HBM Medical